Cargando…
Early Use of Sotrovimab in Children: A Case Report of an 11-Year-Old Kidney Transplant Recipient Infected with SARS-CoV-2
Background: The use of virus-neutralizing monoclonal antibodies has been approved in fragile populations, including kidney transplant recipients, who are at risk of developing severe COVID-19. Sotrovimab is the only currently available anti-SARS-CoV-2 neutralizing monoclonal antibody with activity a...
Autores principales: | Di Chiara, Costanza, Mengato, Daniele, De Pieri, Marica, Longo, Germana, Benetti, Elisa, Venturini, Francesca, Giaquinto, Carlo, Donà, Daniele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028505/ https://www.ncbi.nlm.nih.gov/pubmed/35455495 http://dx.doi.org/10.3390/children9040451 |
Ejemplares similares
-
Therapeutic Options and Outcomes for the Treatment of Children with Gram-Positive Bacteria with Resistances of Concern: A Systematic Review
por: Chiusaroli, Lorenzo, et al.
Publicado: (2023) -
Early Treatments of Fragile Children with COVID-19—Results of CLEVER (Children COVID Early Treatment), a Retrospective, Observational Study
por: Minotti, Chiara, et al.
Publicado: (2023) -
Alternative Antimicrobial Irrigation Strategies for the Treatment of Infections in Children: A Review of the Existing Literature
por: Di Chiara, Costanza, et al.
Publicado: (2023) -
Enteral Linezolid as an Effective Option to Treat an Extremely Preterm Infant with Bacillus cereus Sepsis
por: Minotti, Chiara, et al.
Publicado: (2022) -
Early treatment with sotrovimab monoclonal antibody in kidney transplant recipients with Omicron infection
por: Chavarot, Nathalie, et al.
Publicado: (2022)